Therefore, this study aimed to explore the therapeutic effect of MSC in CRC and the feasibility of MSC to enhance the sensitivity of CD8+ T-αPD1 immunotherapy therapy by recruiting and engineering macrophages through abundant chemokine expression profiles. This evidence concerns the gene CD8A and colorectal carcinoma.